Pramlintide (Symlin) is the short-acting amylin analog FDA-approved 2005 for adjunctive use with insulin in type 1 and insulin-treated type 2 diabetes
Fumel B, Froment P, Holzenberger M, Livera G, Monget P, Fouchcourt S (2015) Expression of dominant-negative thyroid hormone receptor alpha1 in Leydig and Sertoli cells demonstrates no additional defect compared with expression in Sertoli cells only
PT-141, also known as Bremelanotide, acts as a melanocortin receptor agonist that stimulates melanocortin receptors in the brain associated with sexual desire and arousal
A mix containing both ipamorelin and CJC-1295 is specifically thought to stimulate a greater response from the pituitary cells by triggering GH release via different receptors
Current Opinion in Plant Biology
Supports your bodys natural glutathione production